S
Stephanie Jarosek
Researcher at University of Minnesota
Publications - 58
Citations - 1622
Stephanie Jarosek is an academic researcher from University of Minnesota. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 17, co-authored 55 publications receiving 1425 citations. Previous affiliations of Stephanie Jarosek include University of California, Los Angeles.
Papers
More filters
Journal ArticleDOI
Increasing Rates of Contralateral Prophylactic Mastectomy Among Patients With Ductal Carcinoma In Situ
Todd M Tuttle,Stephanie Jarosek,Elizabeth B. Habermann,Amanda K. Arrington,Anasooya Abraham,Todd J. Morris,Beth A Virnig +6 more
TL;DR: The use of CPM for DCIS in the United States markedly increased from 1998 through 2005, and young patient age, white race, recent year of diagnosis, and the presence of lobular carcinoma in situ were significantly associated with higher CPM rates among all surgical patients and all patients undergoing mastectomy.
Journal ArticleDOI
Trends in the incidence and treatment of parathyroid cancer in the United States.
TL;DR: The objectives of this study were to determine the patterns of disease, treatment trends, and outcomes among patients with parathyroid cancer by using a population‐based data source.
Journal ArticleDOI
Patient and Surgeon Characteristics Associated with Increased Use of Contralateral Prophylactic Mastectomy in Patients with Breast Cancer
TL;DR: This study is the first to evaluate specific surgeon characteristics associated with CPM use in patients who underwent surgical treatment for breast cancer in 2006 and 2007 in a single health care system, which included six different hospitals.
Journal ArticleDOI
Propensity-weighted Long-term Risk of Urinary Adverse Events After Prostate Cancer Surgery, Radiation, or Both
TL;DR: It is shown that treatment for prostate cancer, especially combinations of two treatments such as radiation and surgery, carries a significant risk of urinary adverse events such as urethral stricture, which increases with time since treatment, emphasizing that treatments have long-term effects.
Journal ArticleDOI
Lymph node evaluation is associated with improved survival after surgery for early stage gallbladder cancer.
Eric H. Jensen,Eric H. Jensen,Anasooya Abraham,Stephanie Jarosek,Elizabeth B. Habermann,Waddah B. Al-Refaie,Waddah B. Al-Refaie,Selwyn A. Vickers,Beth A Virnig,Todd M Tuttle +9 more
TL;DR: In the absence of LN evaluation, radical resection provides no benefit over cholecystectomy alone, and pathologic evaluation of at least 1 LN was associated with a significant improvement in median overall survival compared with those who had no LN evaluated.